Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

Disclosures & Reports

Public Disclosures

NO Title Date Submission Obligator
10 30% or More Changes in Sales or Profits/Losses (15% or More in the case of Large-scale Corporations) 2019/01/14 HANALL BIOPHARMA CO.,LTD
9 Closure of Stock Transfer (Shareholder's Registry) 2018/12/14 HANALL BIOPHARMA CO.,LTD
8 Organization of Investor Relations Event 2018/11/27 HANALL BIOPHARMA CO.,LTD
7 Organization of Investor Relations Event 2018/11/26 HANALL BIOPHARMA CO.,LTD
6 Organization of Investor Relations Event 2018/10/11 HANALL BIOPHARMA CO.,LTD
5 Organization of Investor Relations Event 2018/08/29 HANALL BIOPHARMA CO.,LTD
4 Implementation and Operation of Compliance Program of the Fair Trade Commission 2018/07/24 HANALL BIOPHARMA CO.,LTD
3 Material Management Information related to Judgment of Investment(특허권 취득) 2018/07/19 HANALL BIOPHARMA CO.,LTD
2 Organization of Investor Relations Event 2018/05/16 HANALL BIOPHARMA CO.,LTD
1 Material Management Information related to Judgment of Investment(특허권 취득) 2018/05/11 HANALL BIOPHARMA CO.,LTD

Electronic Announcement

공시정보 전자공고 목록
NO Title Date Related Data
1 2017 Statement of financial position 2018-03-30

Management Regulation on Public Announcement

공시정보 전자공고 목록
NO Title Date Related Data
1 Management Regulation on Public Announcement 2009-08-31